Merck & Co. Inc. (MRK)

The answer to that question depends on several factors, so let's break them down.

The timing of this morning's rally? Almost simultaneously news broke from both China and the UK of possible drugs to fight coronavirus.

These companies all could be strong -- even if the 2019 nCoV fear spreads.

This is a market that thrives on growth. Tesla has it in spades.

This company made headlines in 2019, and I'm betting on it as a great play -- in many senses of the word -- for this new year.

The company has a collaboration with Merck, and there are far worse partners you could have when working in the cancer segment of biotech.

I have long been enamored with Lisa Su as a Chief Executive.

TG Therapeutics and Exelixis could find themselves on the shopping lists of other companies.

Does it tick the President off that it appears the Chinese would rather not give up in writing any unfair advantages in global trade that they have enjoyed for decades this close to a national election in the U.S.? Of course.

I do expect there to be some early to mid-December profit taking. But to get from here to year end without hitting some mid-month turbulence would be a pleasant surprise.

There are plenty of stocks that have been thrown away for several weeks because of a belief that the Fed and a trade deal will avoid a recession.

Here's how to get in on the trade if it can hold on a pullback to the Oct. 22; also if Facebook's price holds above $186, expect it to go higher.

The nation enters an electoral season. The drug companies for the most part, have no friends on either side of the aisle.

The market is throwing a Halloween sale right now that it doesn't need to throw, and that's an opportunity.

These stocks are priced for total imperfection. That's just what you want.

If there was not a sizable addressable market for Beyond Meat, the competition would not be building as quickly as it is.

Despite the rhetoric from on high, it is possible to find good stock picks in this market.

The stocks of many companies anticipated a more stringent series of tariffs and we didn't get them.

A little bit of luck and a lot of homework can go a long way to make Big Money out of Mad Money. It's buying a Biogen, a Centene, or a Bristol-Myers that could do just that for you.

Let's visit with the charts of MRK.

We don't have enough stock pickers or individuals to handle all the new stock that's been created. And It is trashing the cloud kings, among others.

The aging population is creating a massive tailwind for companies that provide cutting-edge health care.

There are plenty of senior growth companies that can still move higher.

Let me give you the items I want to see before I bless buying anything in what has become a plain, out and out, treacherous market.

The longer-term picture of MRK is positive.

When you have an oversold market you've got a true coiled spring that can rally beyond where it might ordinary go on good news.

Let's visit with the charts and indicators to get another perspective.